Pelish Henry E.
Officer at NUVL
- Sold, on record
- $13.2M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Jul 9, 2026
- Form 144 notices
- 9
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NUVLNuvalent, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale NUVLRoutineOct 15, 2025 2025
Sold 14,205 shares at $90.04 ($1.3M)
Pelish Henry E., Chief Scientific Officer
10b5-1 planSold 17.7% of holdings ($7.2M position)65,963 shares left1.9x usual sizeFollows a Form 144Filing
- 2 Form 144 notice NUVLNoticeJan 5, 2026 +82 days
Filed to sell 5,160 shares ($504k)
Pelish Henry E., Officer
10b5-1 plan0.6x usual sizeFiling
- 3 Form 4 sale NUVLRoutineJan 6, 2026 +1 day
Sold 5,160 shares at $97.24 ($502k)
Pelish Henry E., Chief Scientific Officer
10b5-1 planSold 7.3% of holdings ($6.9M position)65,888 shares left0.6x usual sizeFollows a Form 144Filing
- 4 Form 144 notice NUVLNoticeMar 12, 2026 +65 days
Filed to sell 38,197 shares ($3.8M)
Pelish Henry E., Officer
10b5-1 plan5x usual sizeFiling
- 5 Form 4 sale NUVLUnusualMar 13, 2026 +1 day
Sold 35,104 shares at $98.08 ($3.4M)
Pelish Henry E., Chief Scientific Officer
10b5-1 planSold 34.9% of holdings ($9.9M position)65,604 shares left4.6x usual sizeFollows a Form 144Filing
- 6 Form 4 sale NUVLRoutineApr 9, 2026 +27 days
Sold 3,093 shares at $104.48 ($323k)
Pelish Henry E., Chief Scientific Officer
10b5-1 planSold 4.5% of holdings ($7.2M position)65,604 shares left0.3x usual sizeFollows a Form 144Filing
- 7 Form 144 notice NUVLNoticeJul 9, 2026 +91 days
Filed to sell 2,111 shares ($261k)
Pelish Henry E., Officer
10b5-1 plan0.3x usual sizeFiling
- 8 Form 4 sale NUVLRoutineJul 9, 2026 same day
Sold 2,111 shares at $123.81 ($261k)
Pelish Henry E., Chief Scientific Officer
10b5-1 planSold 3.2% of holdings ($8.1M position)63,493 shares left0.3x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (23)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Jul 10, 2026 | NUVL | Chief Scientific Officer | Form 4 sale | 2,111 | $261k | 3.2% | Routine | SEC |
| Jul 9, 2026 | Jul 9, 2026 | NUVL | Officer | Form 144 notice | 2,111 | $261k | Notice | SEC | |
| Apr 9, 2026 | Apr 13, 2026 | NUVL | Chief Scientific Officer | Form 4 sale | 3,093 | $323k | 4.5% | Routine | SEC |
| Mar 13, 2026 | Mar 16, 2026 | NUVL | Chief Scientific Officer | Form 4 sale | 35,104 | $3.4M | 34.9% | Unusual | SEC |
| Mar 12, 2026 | Mar 12, 2026 | NUVL | Officer | Form 144 notice | 38,197 | $3.8M | Notice | SEC | |
| Jan 6, 2026 | Jan 7, 2026 | NUVL | Chief Scientific Officer | Form 4 sale | 5,160 | $502k | 7.3% | Routine | SEC |
| Jan 5, 2026 | Jan 5, 2026 | NUVL | Officer | Form 144 notice | 5,160 | $504k | Notice | SEC | |
| Oct 15, 2025 | Oct 17, 2025 | NUVL | Chief Scientific Officer | Form 4 sale | 14,205 | $1.3M | 17.7% | Routine | SEC |
| Oct 14, 2025 | Oct 15, 2025 | NUVL | Chief Scientific Officer | Form 4 sale | 10,070 | $895k | 13.2% | Routine | SEC |
| Oct 13, 2025 | Oct 14, 2025 | NUVL | Officer | Form 144 notice | 21,842 | $1.9M | Notice | SEC | |
| Sep 10, 2025 | Sep 12, 2025 | NUVL | Chief Scientific Officer | Form 4 sale | 3,725 | $294k | 5.3% | Routine | SEC |
| Sep 10, 2025 | Sep 10, 2025 | NUVL | Officer | Form 144 notice | 6,158 | $485k | Notice | SEC | |
| Aug 7, 2025 | Aug 8, 2025 | NUVL | Chief Scientific Officer | Form 4 sale | 5,500 | $412k | 8.3% | Routine | SEC |
| Jul 10, 2025 | Jul 11, 2025 | NUVL | Chief Scientific Officer | Form 4 sale | 7,645 | $614k | 11.1% | Routine | SEC |
| Jul 9, 2025 | Jul 9, 2025 | NUVL | Officer | Form 144 notice | 2,145 | $174k | Notice | SEC | |
| Jun 27, 2025 | Jun 27, 2025 | NUVL | Chief Scientific Officer | Form 4 sale | 10,800 | $863k | 14.6% | Routine | SEC |
| Jun 6, 2025 | Jun 10, 2025 | NUVL | Chief Scientific Officer | Form 4 sale | 200 | $16k | 0.3% | Routine | SEC |
| Jun 6, 2025 | Jun 6, 2025 | NUVL | Officer | Form 144 notice | 22,000 | $1.7M | Notice | SEC | |
| Jan 6, 2025 | Jan 8, 2025 | NUVL | Chief Scientific Officer | Form 4 sale | 2,483 | $198k | 4.0% | Routine | SEC |
| Jan 6, 2025 | Jan 6, 2025 | NUVL | Officer | Form 144 notice | 2,750 | $222k | Notice | SEC | |
| Sep 16, 2024 | Sep 18, 2024 | NUVL | Chief Scientific Officer | Form 4 sale | 32,795 | $3.2M | 49.6% | Routine | SEC |
| Aug 23, 2024 | Aug 27, 2024 | NUVL | Chief Scientific Officer | Form 4 sale | 10,500 | $893k | 13.7% | Routine | SEC |
| Aug 23, 2024 | Aug 23, 2024 | NUVL | Chief Scientific Officer | Form 144 notice | 43,295 | $3.6M | Notice | SEC |